Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro

被引：151

作者：

Anderson, JF ^{[1
]}

Rahal, JJ

机构：

[1] Connecticut Agr Expt Stn, New Haven, CT 06504 USA

[2] Cornell Univ, New York Hosp Queens, New York, NY USA

[3] Cornell Univ, Weill Coll Med, New York, NY USA

来源：

EMERGING INFECTIOUS DISEASES | 2002年 / 8卷 / 01期

关键词：

D O I：

10.3201/eid0801.010252

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：107 / 108

页数：2

共 10 条

[1] Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut [J].

Anderson, JF ;

Andreadis, TG ;

Vossbrinck, CR ;

Tirrell, S ;

Wakem, EM ;

French, RA ;

Garmendia, AE ;

Van Kruiningen, HJ .

SCIENCE, 1999, 286 (5448) :2331-2333

[2]

Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P25

[3] Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells [J].

Jordan, I ;

Briese, T ;

Fischer, N ;

Lau, JYN ;

Lipkin, WI .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1214-1217

[4] Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions [J].

Khakoo, S ;

Glue, P ;

Grellier, L ;

Wells, B ;

Bell, A ;

Dash, C ;

Murray-Lyon, I ;

Lypnyj, D ;

Flannery, B ;

Walters, K ;

Dusheiko, GM .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (06) :563-570

[5] Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States [J].

Lanciotti, RS ;

Roehrig, JT ;

Deubel, V ;

Smith, J ;

Parker, M ;

Steele, K ;

Crise, B ;

Volpe, KE ;

Crabtree, MB ;

Scherret, JH ;

Hall, RA ;

MacKenzie, JS ;

Cropp, CB ;

Panigrahy, B ;

Ostlund, E ;

Schmitt, B ;

Malkinson, M ;

Banet, C ;

Weissman, J ;

Komar, N ;

Savage, HM ;

Stone, W ;

McNamara, T ;

Gubler, DJ .

SCIENCE, 1999, 286 (5448) :2333-2337

[6] RIBAVIRIN DISPOSITION IN HIGH-RISK PATIENTS FOR ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

LASKIN, OL ;

LONGSTRETH, JA ;

HART, CC ;

SCAVUZZO, D ;

KALMAN, CM ;

CONNOR, JD ;

ROBERTS, RB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (05) :546-555

[7]

LAYTON M, 2000, W NILE VIRUS FINAL U, P1

[8]

MCCORMICK JB, 1986, NEW ENGL J MED, V314, P320

[9]

ODELOLA HA, 1978, CURRENT CHEMOTHERAPY, V1, P3343

[10] DIFFERENT PATHOGENICITY OF ENCEPHALITIC TOGAVIRUSES IN ORGANOTYPIC CULTURES OF SPINAL-CORD SLICES [J].

SHAHAR, A ;

LUSTIG, S ;

AKOV, Y ;

DAVID, Y ;

SCHNEIDER, P ;

LEVIN, R .

JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 25 (03) :345-352

← 1 →